SAN FRANCISCO, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Zephyr Health, the leading insights-as-a-service company for the Healthcare industry, announced today that it has closed a $17.5 Million funding round led by Google Ventures. Current investors Kleiner Perkins Caufield & Byers and Icon Ventures are also participating in the round. Zephyr Health has received a total of $33.5 million funding to date. "At Google Ventures, we look for companies that work at the intersection of data science and Healthcare," said Blake Byers, General Partner at Google Ventures. "Zephyr Health is at the forefront of healthcare analytics. Zephyr integrates thousands of public and private data sources to provide deep, predictive insights that enable customers to accelerate time to market for drugs, diagnostics and devices." On average it costs Pharmaceutical companies between $1.5 and 2.4 billion to bring a new therapy to market, with only 33% of those products meeting their initial sales goals. Zephyr Health customers, including Fortune 100 Genentech, Gilead, Medtronic, Onyx and Amgen, use the company's Illuminate solution to improve business results across the product lifecycle. The solution's proprietary algorithms link data from thousands of disconnected sources to generate predictive insights that power precise and confident performance across the product lifecycle. "At Zephyr Health we have a strong team, and proven solutions for leading pharmaceutical and medical device companies," said William King, Founder and CEO, Zephyr Health. "With the support of Google Ventures, along with KPCB and Icon, we look forward to a collaborative partnership that will allow us to tap into their vast resources of knowledge and experience, helping us to further expand our business with new products and in new areas." About Zephyr Health Founded in 2011 by William King, Zephyr Health is the leading insights-as-a-service company harnessing the power of global healthcare data for precise and confident product lifecycle performance for biopharmaceutical and medical device companies. From clinical trials to market strategy and sales, our solutions connect data from thousands of sources across the global healthcare ecosystem to produce deep, predictive insights that our customers can use to better connect their therapies to the people who need them the most. Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK and Pune, India. Zephyr Health is venture backed by Kleiner Perkins Caufield & Byers, and Icon Ventures. For more information, please visit: www.zephyrhealth.com. About Google Ventures Google Ventures provides seed, venture, and growth stage funding to the most innovative and promising entrepreneurs across a variety of industries. Founded in 2009, Google Ventures has extensive entrepreneurial experience, deep technical knowledge, and expertise in building high growth, scalable products and companies. Among its 300 investments are Uber, Kabam, Flatiron Health, Cloudera and DocuSign. Google Ventures is headquartered in Mountain View, Calif., with offices in San Francisco, Boston, New York, and London. For more information, please visit www.gv.com. Connect with Zephyr Health: Follow @zephyrhealth on Twitter Connect with Zephyr Health on LinkedIn Want to try it out for yourself? Sign up to learn more about how Insights-as-a-Service can give you a competitive edge. http://go.zephyrhealth.com/diabetes-real-world-evidence For more info: https://zephyrhealth.com/real-world-evidence/
Zephyr Health has announced that it has closed a $33.5m series C funding round, which was led by Zephyr Health . To date, Zephyr Health has received $33.5m in funding, with other investors in the round including Zephyr Health , Caufield & Byers and Icon Ventures . Icon Ventures uses its Icon Ventures solution to integrate thousands of public and private data sources to provide predictive insights, which allow its customers to accelerate time to market for their products.